2-[6-(4-dibenzothiophen-1-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-4-yl]-1,3-benzoxazole
C40H22N4O2S — CID 146513479
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[6-(4-dibenzothiophen-1-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-4-yl]-1,3-benzoxazole
2-[6-(4-dibenzothiophen-1-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-4-yl]-1,3-benzoxazole (PubChem CID 146513479) has the molecular formula C40H22N4O2S and a molecular weight of 622.71 g/mol. Its IUPAC name is 2-[6-(4-dibenzothiophen-1-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-4-yl]-1,3-benzoxazole.
Molecular Properties
| Compound Name | 2-[6-(4-dibenzothiophen-1-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-4-yl]-1,3-benzoxazole |
|---|---|
| PubChem CID | 146513479 |
| Molecular Formula | C40H22N4O2S |
| Molecular Weight | 622.71 g/mol |
| Exact Mass | 622.15 |
| IUPAC Name | 2-[6-(4-dibenzothiophen-1-yl-6-phenyl-1,3,5-triazin-2-yl)dibenzofuran-4-yl]-1,3-benzoxazole |
| SMILES | c1ccc(-c2nc(-c3cccc4c3oc3c(-c5nc6ccccc6o5)cccc34)nc(-c3cccc4sc5ccccc5c34)n2)cc1 |
| InChI | InChI=1S/C40H22N4O2S/c1-2-11-23(12-3-1)37-42-38(27-16-10-22-33-34(27)26-13-4-7-21-32(26)47-33)44-39(43-37)28-17-8-14-24-25-15-9-18-29(36(25)46-35(24)28)40-41-30-19-5-6-20-31(30)45-40/h1-22H |
| InChIKey | WDCMSPQYVJVTBB-UHFFFAOYSA-N |
| XLogP | 10.95 |
| TPSA | 77.84 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 622.71 |
| LogP ≤ 5 | 10.95 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146513479 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.